Study #2023-0653
A long-term follow-up study of subjects with malignancies treated with CRISPR CAR cellular therapies
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hematologic Malignancy;Solid Malignancy
Study phase:
Physician name:
Samer Srour
Department:
Stem Cell Transplantation
For general questions about clinical trials:
1-844-996-5012
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.